These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28801327)

  • 21. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus.
    Takaike H; Uchigata Y; Iwamoto Y; Imagawa A; Iwahashi H; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Maruyama T; Hanafusa T; Makino H
    Ann Med; 2008; 40(5):395-400. PubMed ID: 18484350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of structured group education on glycemic control and hypoglycemia in insulin-treated patients.
    Koev DJ; Tankova TI; Kozlovski PG
    Diabetes Care; 2003 Jan; 26(1):251. PubMed ID: 12502698
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lipohypertrophy].
    Müssig K; Gallwitz B
    Dtsch Med Wochenschr; 2006 Aug; 131(33):1807-8. PubMed ID: 16902904
    [No Abstract]   [Full Text] [Related]  

  • 24. ISPAD Clinical Practice Consensus Guidelines 2014. Sick day management in children and adolescents with diabetes.
    Brink S; Joel D; Laffel L; Lee WW; Olsen B; Phelan H; Hanas R;
    Pediatr Diabetes; 2014 Sep; 15 Suppl 20():193-202. PubMed ID: 25182314
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel approach to preventing diabetic ketoacidosis in a patient treated with an insulin pump.
    Phillips BD; Aurand LA; Bedwell MM; Levy JR
    Diabetes Care; 2003 Oct; 26(10):2960-1. PubMed ID: 14514614
    [No Abstract]   [Full Text] [Related]  

  • 26. The management of lipohypertrophy in diabetes care.
    Hambridge K
    Br J Nurs; 2007 May 10-23; 16(9):520-4. PubMed ID: 17551441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-Mediated Lipohypertrophy.
    Verma R
    N Engl J Med; 2017 Aug; 377(6):573. PubMed ID: 28792866
    [No Abstract]   [Full Text] [Related]  

  • 28. [Multiple insulin injections therapy as an intensive insulin therapy].
    Kishikawa H; Wake N; Shichiri M
    Nihon Rinsho; 1997 Nov; 55 Suppl():249-54. PubMed ID: 9434476
    [No Abstract]   [Full Text] [Related]  

  • 29. Nodules of fibrocollagenous scar tissue induced by subcutaneous insulin injections: a cause of poor diabetic control.
    Wallymahmed ME; Littler P; Clegg C; Haqqani MT; Macfarlane IA
    Postgrad Med J; 2004 Dec; 80(950):732-3. PubMed ID: 15579616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of diabetes at diabetes camps. American Diabetes Association.
    Diabetes Care; 1999 Jan; 22(1):167-9. PubMed ID: 10333921
    [No Abstract]   [Full Text] [Related]  

  • 31. Combined Insulin Deficiency and Endotoxin Exposure Stimulate Lipid Mobilization and Alter Adipose Tissue Signaling in an Experimental Model of Ketoacidosis in Subjects With Type 1 Diabetes: A Randomized Controlled Crossover Trial.
    Svart M; Kampmann U; Voss T; Pedersen SB; Johannsen M; Rittig N; Poulsen PL; Nielsen TS; Jessen N; Møller N
    Diabetes; 2016 May; 65(5):1380-6. PubMed ID: 26884439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experts develop an diabetes educational program].
    Pflege Z; 2013 May; 66(5):301. PubMed ID: 23700781
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of lipohypertrophy.
    Kalra S; Kumar A; Gupta Y
    J Pak Med Assoc; 2016 Jul; 66(7):910-1. PubMed ID: 27427150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sudden death due to diabetic ketoacidosis following power failure of an insulin pump: Autopsy and pump data.
    Kjærulff MLBG; Astrup BS
    J Forensic Leg Med; 2019 Apr; 63():34-39. PubMed ID: 30856551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ketogenic diet as a trigger for diabetic euglycaemic ketoacidosis in a patient under treatment with iSGLT2].
    Nubiola A; Ternianov A; Remolins I
    Hipertens Riesgo Vasc; 2020; 37(1):39-41. PubMed ID: 31734176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog).
    Roper NA; Bilous RW
    Diabet Med; 1998 Dec; 15(12):1063-4. PubMed ID: 9868982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment Modality-Dependent Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes: Danish Adult Diabetes Database Study.
    Hoshina S; Andersen GS; Jørgensen ME; Ridderstråle M; Vistisen D; Andersen HU
    Diabetes Technol Ther; 2018 Mar; 20(3):229-234. PubMed ID: 29437465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application and practice of intensive insulin therapy].
    Kishikawa H; Soejima H; Tamama Y; Araki E; Shichiri M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():297-303. PubMed ID: 12387009
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cases: "safety" technology: a hidden cause of diabetic ketoacidosis.
    Yu CH
    CMAJ; 2012 Mar; 184(5):557-8. PubMed ID: 22371509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.